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Problem Identification
■ Nationally, 5 people die every hour
from opioid overdose. 1

■ In 2017, 101 Vermonters died from
opioid overdose* (16.2 fatalities per
100,000 residents). This rate
increased 5% from the previous year,
and has more than doubled since
2010. 2
■ 12 of these deaths occurred in
Washington County. 2

■ Preliminary data indicate 3 people died
from opioid-related causes in
Washington County in the first two
months of 2018. 2

From the Vermont Department of Health: Opioid-Related
Fatalities Among Vermonters.

*Defined as accidental or undetermined opioidrelated fatality (excludes suicides).
1. Centers for Disease Control (2018). Opioid Basics: Understanding the epidemic.
2. Vermont Department of Health. (2018). Opioid-Related Fatalities Among Vermonters.
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Description of need

■ The Central Vermont Medical Center
Community Health Needs Assessment
for 2016 identified addressing drug
abuse as a priority health need. 3

Opioid-Related Fatalities in Washington County
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■ There were 1,361 EMS responses for
potential overdose in Vermont in 2015. 4
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Data from the Vermont Department of Health: OpioidRelated Fatalities Among Vermonters.

3.
4.
5.
6.

■ Naloxone is an effective, low risk, and
easy to use reversal agent for opioid
overdose. 95% of Vermonters who
reported using naloxone for a potential
overdose said that it reversed the
overdose. 5

■ According to a recent survey of syringe
exchange clients in Vermont, 68% were
interested in potentially receiving more
training on overdose reversal. 6

Central Vermont Medical Center. (2016). Community Health Needs Assessment.
VanDonsel, et al. (2016). Opioids in Vermont: Prevalence, Risk, and Impact.
Vermont Department of Health. (2018). Naloxone Distribution and Administration in Vermont- Data Brief.
Bakhtyari, et al. (2018). Barriers Encountered by Syringe Exchange Clients in VT.
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Public health cost
■ The opioid epidemic has cost
the U.S. over a trillion dollars
since 2001, with the majority of
that cost coming from lost
earnings and productivity due to
overdose deaths. 7
■ The average cost to treat
overdose patients admitted to
hospital intensive care units is
$92,408. 8
■ Naloxone distribution through
syringe exchange services has
been shown to provides good
overall value for money
invested. 9
From Altarum: Economic Toll of Opioid Crisis in U.S. Exceeded $1 Trillion
7. Altarum. (2018). Economic Toll of Opioid Crisis in U.S. Exceeded $1 Trillion Since 2001.
8. Stevens, J., et.al. (2017). Critical care crisis among opioid overdoses.
9. Uyei, J., et al. Effects of naloxone distribution…..a cost-effectiveness modelling study.
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Unique cost considerations in host community
■ The Vermont Department of Health provides
naloxone kits to local organizations free of cost
for distribution to at-risk Vermonters.
– The cost of a two-dose kit for the Department
of Health is $75 *
■ In 2017 Vermont CARES distributed 240 naloxone
kits and provided 15-30 minutes of individual
client education for each kit given out. *
– This amounts to a total of 60-120 hours of
staff time spent on naloxone training.
■ Clients reported 40-55 overdose reversals
attributed to the use of those kits. *

Moseley Covered Bridge in Northfield.
Image by Jerrye & Roy Klotz, courtesy of Wikimedia commons.

■ The cost per life saved is $325- $450
* P. Jacobsen, personal communication, June 5th, 2018)
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Community Perspective on
Issue and Support for Project
Vermont CARES is the largest and longest standing AIDS Service
Organization in the state of Vermont. Available client services include
substance abuse support, such as clean needles & safe injection supplies,
mobile exchanges, free syringe disposal, overdose prevention education,
overdose reversal kits (naloxone), and treatment option counseling10

■ Regarding the education currently provided to clients when they receive a naloxone kit, Peter
Jacobsen (executive director) explained that Vermont CARES staff provide a “thorough and
thoughtful training including the steps in how to identify an overdose, what to do, how to administer
the naloxone itself, and how to follow up with paramedics to ensure follow up care.”
■ Theresa Vezina (assistant director) shared that, in addition to the in-person training “…the
Department of Health kit has an information handout with it, but few clients read it. What we’d
really like to incorporate next is a video on how to use naloxone that could be distributed, put on
people’s phones, and shown to friends”.
■ Having a short video available would also give the option of pulling it up on a tablet and showing it
to small groups of people, allowing questions and answers to be generated in a group environment,
according to Mr. Jacobsen.
10. Vermont Cares. (2018). Vermont Cares Story.
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Intervention and Methodology
■ Syringe exchange clients were selected as the target
for intervention as drug related fatalities involving
heroin have increased in Vermont over the past 5
years (fatalities related to prescription opioids have
been stable). 11
■ Vermont CARES community partners were
interviewed and education surrounding naloxone was
identified as a need in the local community.
■ Specifically, a brief four to five minute video
presentation was identified as a need to supplement
existing education; currently education is provided in
a 1:1 format and take-home materials are print only.

■ Existing training guidelines used by Vermont CARES for naloxone education were
reviewed and the content which needed to be covered was noted.
■ Educational videos on naloxone use currently available online were found and viewed to
determine if anything already in existence met this need.
11. Vermont Department of Health. (2017). Opioid Misuse, Abuse, & Dependence in Vermont- Data Brief.
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Intervention and Methodology
■ Primary goals for the video:
– Easy to understand (grade 4-5 reading
level per national recommendations for
patient educational material)
– Comprehensive; should cover all
educational content in existing training
– Engaging
– Format that would be easily accessible
on phones
■ A draft of the video presentation and script
was prepared and subsequently reviewed by
the community partner for content, format,
and any potentially biased language
■ The video presentation was created using
VideoPad Video Editor®. Audio was recorded
and edited in Audacity® 2.2.2. Final
product was saved in mp4 file format.
5b

Results/Response
The final product was
a four minute video
covering the
information provided
in the existing
Vermont CARES
training on naloxone.

■ Vermont CARES will use the video as part of its naloxone training for clients.
■ Theresa Vezina : “I can’t tell you how much I absolutely love this video, and how helpful it is going
to be for our clients and our staff!”
6

Evaluation of effectiveness
Goal: Video presentation is easy to understand.
Evaluation: Appropriate reading of level for script* confirmed via online Lexile analysis
*drug names were removed from script for analysis

Additional Proposed Evaluation:
Assess client response to the following before and after viewing the video presentation:
Are you comfortable identifying the signs of and opioid overdose and administering naloxone if needed? Yes/No

Goal: Video covers all educational content in existing training.
Evaluation: Final product was compared to existing training material from Vermont CARES
and coverage of all content was verified.

Goal: Video presentation is easily accessible on phones.
Evaluation: Presentation was accessed without difficulty on both Android and iOS phones.
7a

Limitations
■ Direct client perspective on the issue was
difficult to obtain due to the inability to
guarantee anonymity for interviewees.
■ Time limitations prevented a thorough
assessment of client education gaps and
preferences in educational materials prior to
production.
■ Time and budget limitations affected the
production quality of the video presentation.
■ Distribution through the Vermont CARES
program primarily reaches individuals who
use intravenous substances. Vermonters at
risk of overdose from oral or prescription
opioids are less likely to benefit.
7b

Recommendations for future interventions/projects
■ Consider uploading presentation to
YouTube to reach a broader
audience; assess any potential
liability prior to doing so.
■ Vermont CARES currently provides
fentanyl test kits and training in their
use; another brief video could be
created to provided education on
this topic.
■ Contacting medical personnel is an
important part of caring for
someone suffering from a drug
overdose; clients may be hesitant to
do so for various reasons. Vermont
CARES has expressed interest in
assessing if clients are reluctant to
contact the paramedics and if so,
why. A qualitative survey could be
created to address this question.
8
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